Francesco Sassi
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Author Correction: Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling.
Journal: Nature cell biology
Published: July 31, 2026
Author Correction: The genomic landscape of response to EGFR blockade in colorectal cancer.
Journal: Nature
Published: February 16, 2026
Efficacy of dual KRASG12D-EGFR blockade versus triple combinations in patient-derived models of KRASG12D-mutant colorectal cancer.
Journal: Cell death & disease
Published: October 07, 2025
Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer.
Journal: Science translational medicine
Published: May 21, 2025
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients.
Journal: Nature communications
Published: April 26, 2023
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient.
Journal: Frontiers in oncology
Published: December 23, 2022
MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis.
Journal: Molecular oncology
Published: November 04, 2022
CONNECTOR, fitting and clustering of longitudinal data to reveal a new risk stratification system.
Journal: Bioinformatics (Oxford, England)
Published: October 31, 2022
Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 16, 2022
Effective drug combinations in breast, colon and pancreatic cancer cells.
Journal: Nature
Published: July 02, 2021
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 12, 2021
Last Updated: 09/26/2026